Clostridium Vaccine Market - Global Industry Analysis, Size, Trends, Growth, Trends, and Forecast 2018 - 2028

  • Single User License $3500

Clostridium Vaccine Market - Global Industry Analysis, Size, Trends, Growth, Trends, and Forecast 2018 - 2028

Status : August, 2020 | Biotechnology | PPT format

Report Digest


Global Clostridium Vaccine Market: Overview

Gram Positive Bacterium, Clostridium Difficile, is cause for concern, particularly because infections related to this are a cause for hospital acquired infectious diarrhoea. And, the fact is widely recognized. And, this requires developing a prevention vaccine for the disease, to counter the anaerobic toxin which transfers through fecal oral route.

The global clostridium vaccine market would thus note a steady growth over the forecast period of 2018 - 2028. The robust CAGR (Compound Annual Rate Growth) will chart an upward growth curve and create lucrative growth opportunities in the global clostridium market. In, turn, this will lead to improvement in market worth.

Global Clostridium Vaccine Market: Notable Development

The global clostridium vaccine market is set to witness growth and a number of notable developments are paving the way for the same. The competitive landscape is also duly impacted by these developments. A deep dive can be had in an upcoming report by Transparency Market Research.

2017: Pfizer led phase II trial of clostridium difficile vaccine – PF 06425090 – to ensure safety, efficacy, tolerability and immunogenicity in adults considered healthy, falling in the age group of 65 to 85. The phase III happened in 2017 in which a large number of 16000 participants joined.

2016: Valneva SE completed phase II for VLA84, a prophylactic vaccine developed to prevent infections of C. Difficile.

This shows how players are focused at improving Research and Development), leading the way forward. This is particularly significant for nations as of now there are not any alternative therapies available, except the antibiotics. In serious cases, it might be surgery called fecal microbiota transplant.

The global clostridium vaccine market is highly consolidated. And, key players in the global clostridium market are Valneva SE and Pfizer, Inc. Other players include Sanofi-Aventis, Merck & Co., Eli Lilly and Company, and Boehringer Ingelheim.

Global Clostridium Vaccine Market:  Key trends and driver

The global clostridium vaccine market is being driven on to a high growth trajectory, owing to a number of trends and drivers. Some of the focal ones are spelled out below.

  • C. Difficile is infections are seeing a rise in incidence. And, that is not all. Recurrence in infection is also noted. Besides, resistance to antibiotics is further compounding the situation further. As available treatment options fall short on a number of counts, developing vaccines will ensure a firm grasp on the growing market share. To gauge the scale of the problem, it is essential to know that in 2015, CDC (Centres for Disease Control and Prevention) revealed that in the United States, half a million people suffered from infections of clostridium difficile. Thus, it comes as no surprise that major players are in their testing phase. The idea is to capture the unmet demand for preventive measures.
  • There is a high incidence of zoonotic diseases noted, particularly in swine. It is a concern owing to a high demand for pork. Other animals include poultry, ovine and caprine. In the United States alone, 6 out of 10 infectious diseases, spread from animals. Besides, 3 out of every 4 in the country are from the set of emerging infectious diseases, contracted from animals. This will also push the market on a high growth treajectory.

Global Clostridium Vaccine Market:  Regional Analysis

North America is set to dominate the market landscape owing to a high prevalence of clostridium infections. Besides, there is also a high level of awareness regarding the sane. This makes more and more people seek for preventive measures, promising high growth to the market.

The report is segmented into the following:

By Vaccine

  • PF-06425090
  • VLA84

The study presents a granular assessment and quantitative evaluation of:

  • Key growth factors and prominent trends
  • Size and share of key segments in overall market
  • Key challenges and winning imperatives
  • Factors shaping competitive landscape
  • Insights into how contours of market will change in coming years
  • Technological advances
  • New avenues and imminent investment pockets
  • Regulatory landscape shaping current and future strategies of companies

The region-wise assessment includes market dynamics in:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The study is prepared with the help of an extensive primary and secondary research. Primary research includes but not limited to interactions, interviews, surveys, and events. Opinions of policy makers and industry experts are carefully integrated into the insights to complement primary research. Volumes of secondary data gleaned through renowned paid sources, annual statements, reputed journals, and government documents offer insights into current dynamics and key evolution trajectories the market is likely to assume. The research employs various industry-wide analytics methods and well-established methodologies to ascertain the attractiveness of key segments. Further, it evaluates the lucrativeness of key regions and factors underlying their maturity. The insights notably include a detailed analysis of forces behind vendor differentiation and offers insight into investment-decision making by prominent players.

The report strives to enlighten businesses and industry stakeholders on multiple facets of the growth dynamic of the market, the key of which include answers to:

  • Which key factors will shape the competitive landscape?
  • Which trends will stimulate research and development activities in different geographies?
  • Which are the lucrative growth areas and what is the size of potential they are likely contribute to the overall market?
  • Which disruptions in market growth are likely to come with the new business models?
  • Which are some of the recent overhauls in policies that may change the course of the market significantly?
  • Which are the geographies that will form sizable sources of new streams to new and established players alike?
  • How are top players likely to realign their strategy to counter the forces of competition?
  • Which key strategies emerging players are likely to focus on to consolidate their position?
  • Which changes in end-user preferences might affect the status quo held by the leading players?
  • Which are some of the game-changing innovations influencing the projected share and revenue of the market and its segments?

Note: Utmost care has invariably been taken to present data and arrive at statistics at all the TMR Research reports. Meanwhile, some recent developments and new industry trends may take time to be included in the reports.